Marinus Pharmaceuticals, Inc.
USD0.55
+0.00 (+0.00%)
CEO
Scott N. Braunstein
IPO Date
2014-07-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.55
Prev. Close
$0.55
Day Low
$0.55
Day High
$0.55
52W Low
$0.22
52W High
$10.50
Market Cap
$0.03B
Volume
1.10M
| -2.0 |
| 31 Dec 2021 | FY | 90.4% | -662.5% | -190.1% | -74.3% | 0.76 | 3.03 | -1.1 |
| 31 Dec 2020 | FY | -2839.8% | -3879.0% | -48.6% | -44.3% | 0.00 | 13.06 | -1.2 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -61.3% | -54.4% | 0.01 | 11.72 | -0.5 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -53.8% | -48.8% | 0.00 | 10.70 | -0.8 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -32.6% | -31.1% | 0.00 | 13.18 | -2.5 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -133.4% | -91.1% | 0.24 | 3.75 | -0.2 |
| 31 Dec 2015 | FY | 0.0% | 0.0% | -53.0% | -41.7% | 0.16 | 7.77 | -1.1 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | -26.3% | -21.6% | 0.17 | 24.59 | -1.5 |
| -0.5 |
| 31 Mar 2024 | Q1 | 88.4% | -503.6% | 235.3% | -28.2% | -6.85 | 3.07 | -0.8 |
| 31 Dec 2023 | Q4 | 85.9% | -580.9% | -249.1% | -24.4% | 6.58 | 4.07 | -0.9 |
| 30 Sept 2023 | Q3 | 93.8% | -449.3% | -60.5% | -16.4% | 1.36 | 6.38 | -0.8 |
| 30 Jun 2023 | Q2 | 93.7% | -525.1% | -55.7% | -15.9% | 1.84 | 7.60 | -1.1 |
| 31 Mar 2023 | Q1 | 98.0% | -333.1% | -40.6% | -15.2% | 1.20 | 9.26 | -0.6 |
| 31 Dec 2022 | Q4 | 95.9% | -479.1% | -29.6% | -13.2% | 0.63 | 4.38 | -0.3 |
| 30 Sept 2022 | Q3 | 97.9% | 3061.3% | 87.4% | 38.8% | 0.89 | 8.41 | 0.2 |
| 30 Jun 2022 | Q2 | -1100.8% | -2203.0% | -821.0% | -36.1% | 15.12 | 4.37 | -0.3 |